TB Treatment: The treatment, known as BPaL, combines the antibiotics bedaquiline, pretomanid and linezolid, and has received regulatory approval in more than 60 countries since 2019, according to the non-profit TB Alliance, which developed it.
The India TB report (2024) which released earlier this week, suggests that the gap between the estimated number and actual cases of tuberculosis (TB) is closing. One of the most significant factors that has contributed to this is the tracking of all TB patients, happening via the government s Ni-kshay portal